Safety and immunogenicity of a novel multivalent OspA vaccine against Lyme borreliosis in healthy adults: a double-blind, randomised, dose-escalation phase 1/2 trial
Titel:
Safety and immunogenicity of a novel multivalent OspA vaccine against Lyme borreliosis in healthy adults: a double-blind, randomised, dose-escalation phase 1/2 trial
Auteur:
Wressnigg, Nina Pöllabauer, Eva-Maria Aichinger, Gerald Portsmouth, Daniel Löw-Baselli, Alexandra Fritsch, Sandor Livey, Ian Crowe, Brian A Schwendinger, Michael Brühl, Peter Pilz, Andreas Dvorak, Thomas Singer, Julia Firth, Clair Luft, Benjamin Schmitt, Bernhard Zeitlinger, Markus Müller, Markus Kollaritsch, Herwig Paulke-Korinek, Maria Esen, Meral Kremsner, Peter G Ehrlich, Hartmut J Barrett, P Noel